## Abstract Epidermal growth factor (EGF) receptor status is a useful prognostic indicator in women with breast cancer. Lack of standardization and correlation of methodology for the detection of EGF receptor has hampered its further evaluation. EGF receptor status was ascertained by immunohistoche
Measurement of occupied and non-occupied epidermal growth factor receptor sites in 216 human breast cancer biopsies
✍ Scribed by Nicole Falette; Marie-F. Lefebvre; Farid Meggouh; Michèle Eynard; Elisabeth Garin; Simone Saez
- Publisher
- Springer US
- Year
- 1991
- Tongue
- English
- Weight
- 757 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Epidermal growth factor receptor (EGFr) assays were performed by 3 different methods on 246 human primary breast carcinomas. Scatchard analyses of multipoint binding data on 19 of the first 209 tumours, performed by a displacement method, demonstrated that the majority of tumours exhibited 2 classes
Binding capauties and apparent dissociation constants of . receptors for [D-Trp'l-luteinizing hormone-releasing hormone ([D-Trp6]-LH-RH), somatostatin (SS-14), epidermal growth factor (EGF), and estrogen and progesterone were determined in 500 breast cancer specimens using multipoint assays. Specifi
An association exists in primary human breast tumors between high epidermal growth factor receptor (EGFR) expression and a reduced number or even absence of estrogen receptors (ER). To determine whether an increase in EGFR expression might alter the estrogen responsiveness of an ERpositive human bre